
Science and technology firm Merck has joined forces with Inbrain Neuroelectronics to jointly develop the next generation of bioelectronic therapies for severe chronic diseases. Inbrain Neuroelectronics is a medtech, deeptech and digital health company engaged in the development of graphene-based neural interfaces and intelligent neuromodulation systems.















